This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)
C3_RETROPERITONEUM_PERITONEUM_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
581 |
4. Check minimum number of eventsNone |
581 |
5. Include endpointsNone |
581 |
6. Filter based on genotype QC (FinnGen only) |
581 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 581 | 414 | 167 |
| Unadjusted period prevalence (%) | 0.12 | 0.14 | 0.07 |
| Median age at first event (years) | 66.69 | 66.20 | 67.92 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 213
- Matched controls
- 2130
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
332.8
128.7
119
8
130
Kela drug reimbursment
Malignant tumour
+∞
112.8
98
*
A03FA01
ATC
metoclopramide; systemic, rectal
26.7
89.8
142
148
WX302
NOMESCO Finland
Thoracal epidural anesthesy
106.7
87.6
92
15
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
72.1
65
*
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
+∞
67.3
61
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
843.2
65.6
61
*
JN4BD
NOMESCO Finland
Extensive body CT
33.4
65.2
87
43
A04AA01
ATC
ondansetron; systemic, rectal
41.9
64.0
80
30
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
29.1
63.9
89
51
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
58.0
53
*
JAL30
NOMESCO Finland
Omentectomy
188.6
55.9
56
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
52.3
48
*
8461/3-C48.2
ICD-O-3
High grade serous carcinoma of peritoneum, NOS
+∞
51.1
47
*
Z51.5
ICD-10 Finland
Palliative care
45.8
49.4
60
18
B01AB10
ATC
tinzaparin; parenteral
23.1
47.9
71
45
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
47.7
44
*
R18
ICD-10 Finland
Ascites
72.0
44.7
50
9
L03AA13
ATC
pegfilgrastim; parenteral
+∞
44.3
41
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
43.2
40
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
43.2
40
*
N02AA05
ATC
oxycodone; systemic
10.6
39.9
87
130
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
39.9
37
*
L03AA02
ATC
filgrastim; parenteral
+∞
39.9
37
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
35.4
33
*
JN4AD
NOMESCO Finland
Body CT examination
22.9
34.4
50
28
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
25.4
34.1
48
24
A04AA55
ATC
palonosetron, combinations; systemic
+∞
28.8
27
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
28.8
27
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
28.8
27
*
WX402
NOMESCO Finland
General anaesthesia
8.1
28.4
71
124
TPH07
NOMESCO Finland
Cathetrisation of artery
8.6
27.8
66
106
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
+∞
27.7
26
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
27.7
26
*
B01AB05
ATC
enoxaparin; parenteral
5.1
27.0
118
415
JAL00
NOMESCO Finland
Biopsy of peritoneum
106.9
26.3
28
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.2
26.0
107
348
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
281.7
25.2
25
*
WW500
NOMESCO Finland
Blood transfusion
16.7
24.8
40
29
JN3BD
NOMESCO Finland
Extensive abdominal CT
7.7
24.5
62
108
L02BG04
ATC
letrozole; oral
76.8
24.4
27
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
24.4
23
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
24.4
23
*
LCD00
NOMESCO Finland
Hysterectomy
12.3
23.7
44
44
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.5
23.7
42
38
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
30.0
23.4
31
12
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
+∞
23.4
22
*
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
256.4
23.1
23
*
8461/3-C48.1
ICD-O-3
High grade serous carcinoma of specified parts of peritoneum
+∞
22.3
21
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
22.3
21
*
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
21.2
20
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
85.7
21.1
23
*
JAH00
NOMESCO Finland
Laparotomy
25.6
21.0
29
13
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
23.7
20.6
29
14
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
40.2
20.3
25
7
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
20.1
19
*
JAH01
NOMESCO Finland
Laparoscopy
14.8
19.7
33
26
JEA00
NOMESCO Finland
Appendectomy
9.3
19.2
41
53
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.7
18.8
74
215
XX3DW
NOMESCO Finland
Time consuming IT work
11.1
18.2
35
37
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
+∞
18.0
17
*
8858/3-C48.0
ICD-O-3
Dedifferentiated liposarcoma of retroperitoneum
+∞
18.0
17
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
18.0
17
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
20.9
17.8
26
14
A04AD12
ATC
aprepitant; systemic
+∞
16.9
16
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
16.9
16
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
19.1
16.0
24
14
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
15.8
123
617
A79
ICPC
Malignancy NOS
+∞
15.8
15
*
C48.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of retroperitoneum and peritoneum
+∞
15.8
15
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
11.8
15.8
29
28
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
10.2
15.6
31
35
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
19.7
15.5
23
13
WX408
NOMESCO Finland
General anesthesy, balanced
3.7
15.3
82
306
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
14.8
14
*
C48.03
ICD-10 Finland
Malignant tumor of the retroperitoneal space leiomyosarcoma
+∞
14.8
14
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
+∞
14.8
14
*
8850/3-C48.0
ICD-O-3
Liposarcoma, NOS, of retroperitoneum
+∞
14.8
14
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
160.6
14.7
15
*
ZX120
NOMESCO Finland
Intravenous
6.2
14.4
40
76
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
80.4
13.8
15
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
13.7
13
*
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
+∞
13.7
13
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
13.7
13
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
13.7
13
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
13.7
13
*
JN4CD
NOMESCO Finland
Very extensive body CT
20.7
13.2
19
10
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.3
13.1
82
338
JN3AD
NOMESCO Finland
Abdominal CT examination
6.3
13.0
35
64
8890/3-C48.0
ICD-O-3
Leiomyosarcoma, NOS, of retroperitoneum
+∞
12.6
12
*
C48.19
ICD-10 Finland
Malignant tumor in specified location in peritoneum other or unspecified histlogy
+∞
12.6
12
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
+∞
12.6
12
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
12.6
12
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
19.5
12.3
18
10
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.3
12.2
48
134
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.7
12.1
43
108
R50.9
ICD-10 Finland
Fever, unspecified
4.9
12.0
41
99
WZC30
NOMESCO Finland
Teaching
5.2
11.6
37
83
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
11.6
11
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
11.6
11
*
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
11.6
11
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
11.6
11
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
16.2
11.5
18
12
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
37.3
11.4
14
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
7.3
10.9
26
40
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
10.0
10.8
21
23
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
15.3
10.7
17
12
S18
ICPC
Laceration/cut
2.7
10.6
106
575
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
115.5
10.5
11
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
115.5
10.5
11
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
11.5
10.5
19
18
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.5
10
*
C48.29
ICD-10 Finland
Malignant tumor in unspecified localization in peritoneum other or unspecified histology
+∞
10.5
10
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
+∞
10.5
10
*
C48.2
ICD-10 Finland
Malignant neoplasm: Peritoneum, unspecified
+∞
10.5
10
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.1
10.4
64
256
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
14.1
10.4
17
13
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
42.2
10.1
12
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
10.3
10.0
19
20
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
57.7
9.7
11
*
KAC00
NOMESCO Finland
Nephrectomy
104.5
9.5
10
*
WF004
NOMESCO Finland
Palliative radiotherapy
104.5
9.5
10
*
C48.20
ICD-10 Finland
Malignant tumor in unspecified localization in the peritoneum without histology
+∞
9.4
9
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
9.4
9
*
C48.1
ICD-10 Finland
Malignant neoplasm: Specified parts of peritoneum
+∞
9.4
9
*
X77
ICPC
Malignant neopl genital female other
+∞
9.4
9
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
9.4
9
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
9.4
9
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.3
8.9
27
57
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
8.9
49
179
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
52.2
8.8
10
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
17.2
8.7
13
8
HA1AA
NOMESCO Finland
X-ray mammography
7.2
8.6
20
30
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
28.8
8.6
11
*
JFB30
NOMESCO Finland
Right hemicolectomy
28.8
8.6
11
*
WF002
NOMESCO Finland
Radical radiotherapy
28.8
8.6
11
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
93.6
8.5
9
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
8.4
8
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
8.4
8
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
8.4
8
*
9680/3-C48.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of retroperitoneum
+∞
8.4
8
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
8.4
8
*
9052/3-C48.2
ICD-O-3
Epithelioid mesothelioma, malignant of peritoneum, NOS
+∞
8.4
8
*
A06AH03
ATC
naloxegol; oral
+∞
8.4
8
*
C48.80
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum without histology
+∞
8.4
8
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
8.4
8
*
JFB00
NOMESCO Finland
Partial resection of small intestine
15.3
8.3
13
9
N02BE01
ATC
paracetamol; systemic, rectal
3.7
8.3
196
1615
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.4
8.2
21
36
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
18.0
8.2
12
7
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
7.8
91
512
Z51.88
ICD-10 Finland
Other specified medical care
10.6
7.7
14
14
C61
ICD-10 Finland
Malignant neoplasm of prostate
82.9
7.5
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
82.9
7.5
8
*
JFF10
NOMESCO Finland
Loop enterostomy
82.9
7.5
8
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.0
7.4
29
80
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.9
7.4
14
15
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.3
7
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
7.3
7
*
9050/3-C48.2
ICD-O-3
Mesothelioma, malignant of peritoneum, NOS
+∞
7.3
7
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.0
7.3
17
26
D70.82
ICD-10 Finland
Drug-induced neutropenia
31.2
7.2
9
*
A02BC02
ATC
pantoprazole; systemic
2.3
7.1
152
1111
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.6
7.1
32
100
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
8.0
7.0
15
20
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
17.4
6.8
10
6
JFB46
NOMESCO Finland
Resection of sigmoid colon
17.4
6.8
10
6
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
71.9
6.5
7
*
PJA12
NOMESCO Finland
Sentinel node biopsy
71.9
6.5
7
*
SPAT1109
SPAT
Analgesia with portable analgesic pump
71.9
6.5
7
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
71.9
6.5
7
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
14.9
6.5
10
7
B03XA02
ATC
darbepoetin alfa; parenteral
14.9
6.5
10
7
KA1AE
NOMESCO Finland
Kidney ultrasound examination
8.6
6.4
13
16
N02AX02
ATC
tramadol; systemic, rectal
2.1
6.3
103
655
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
6.3
6
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
+∞
6.3
6
*
TJA10
NOMESCO Finland
Laparocentesis
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
1510
Kela drug reimbursment
Niraparib
+∞
6.3
6
*
8460/3-C48.2
ICD-O-3
Low grade serous carcinoma of peritoneum, NOS
+∞
6.3
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.3
6
*
3009
Kela drug reimbursment
Niraparib
+∞
6.3
6
*
D74
ICPC
Malignant neoplasm stomach
+∞
6.3
6
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
27.6
6.3
8
*
JFB43
NOMESCO Finland
Left hemicolectomy
27.6
6.3
8
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
260
185
24.63
306.18
17.8
1.5
245.9
24.3
u/ml
6.34
255
177
251
252
16.78
239.37
3.1
1.4
3.6
4.0
ug/l
0.10
172
193
137
105
16.77
149.46
2.4
1.8
203.3
75.1
u/ml
0.50
114
84
221
634
5.01
73.68
5.4
2.4
0.8
0.8
mmol/l
4.08
214
575
453
2292
5.43
70.46
14.7
3.6
9.7
11.8
umol/l
3.07
446
2141
410
1987
4.61
65.72
9.5
3.4
32.0
35.5
g/l
19.30
397
1828
398
1997
4.15
58.01
6.3
3.5
—
—
—
0
0
265
1020
3.94
57.12
3.5
1.9
—
—
—
0
0
448
2543
4.33
52.20
26.7
6.3
4.1
4.2
e9/l
0.84
399
2199
143
388
4.56
49.19
2.7
1.9
49.0
33.6
u/l
0.44
122
317
166
523
4.04
46.49
8.7
7.0
0.6
1.5
mmol/l
2.32
145
417
132
368
4.35
43.45
8.7
7.2
1.1
1.4
mmol/l
5.07
132
357
125
347
4.32
41.25
2.1
1.9
0.2
0.2
g/l
0.65
111
316
147
462
3.92
40.84
2.9
2.2
7.7
6.7
umol/l
0.27
132
391
30
16
19.72
38.10
1.1
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
124
5.88
34.34
3.2
3.1
0.4
0.4
u/ml
0.15
32
74
87
219
4.50
32.23
10.1
10.4
—
—
—
0
0
364
2169
2.82
31.67
9.0
5.3
1.2
1.2
mmol/l
6.75
353
1898
97
288
3.84
28.62
1.6
1.5
—
—
—
0
0
286
1581
2.59
27.79
8.6
2.0
2.3
2.4
mmol/l
1.13
264
1293
27
22
12.82
27.40
2.0
1.3
18.0
16.8
ug/l
0.15
27
22
375
2380
2.62
26.93
9.8
5.4
1.2
1.2
mmol/l
7.26
332
2014
270
1483
2.53
26.19
3.7
2.2
56.4
57.5
u/l
0.12
252
1346
163
700
2.85
25.99
3.2
2.8
4.4
3.7
e6/l
0.25
87
360
257
1398
2.50
25.22
6.6
2.5
32.2
30.4
u/l
0.62
248
1334
171
771
2.73
24.68
3.2
2.6
1.1
1.8
e6/l
0.73
95
431
165
740
2.72
23.98
1.9
1.7
—
—
—
0
0
28
31
9.44
23.13
1.6
1.2
10690.6
206005.7
e6/l
0.49
14
18
481
3598
2.96
22.52
17.4
5.2
93.7
75.6
u/l
6.27
469
3288
231
1247
2.42
22.47
3.6
3.0
0.7
0.4
e6/l
0.75
164
940
243
1342
2.39
22.45
3.8
3.0
22.0
110.6
e6/l
1.12
180
1033
29
36
8.43
21.94
1.6
1.2
781.3
2049.8
e6/l
1.33
21
25
74
224
3.64
21.00
10.8
9.6
24.6
24.8
mmol/l
0.19
74
204
125
522
2.78
20.57
1.9
1.7
—
—
—
0
0
124
521
2.75
20.14
1.9
1.8
—
—
—
0
0
433
3156
2.46
19.91
6.6
4.7
287.0
3140.4
e6/l
—
10
37
392
2792
2.24
18.18
7.7
4.2
6.8
6.8
mmol/l
0.18
383
2597
411
4943
0.42
18.17
4.3
5.3
2.8
2.7
mmol/l
0.19
360
4495
178
930
2.32
17.96
5.6
2.2
2.5
2.4
mmol/l
7.36
161
800
398
4836
0.44
17.62
4.0
4.7
4.7
4.7
mmol/l
0.15
359
4400
393
4791
0.44
17.27
3.9
4.7
1.4
1.5
mmol/l
3.90
349
4345
128
601
2.45
16.28
2.6
2.3
20.8
23.0
%
1.08
109
512
373
4607
0.47
16.02
5.6
6.2
41.1
40.2
mmol/mol
1.03
343
4217
133
647
2.37
15.57
2.5
2.2
2.1
2.4
g/l
3.67
126
601
75
278
2.95
15.18
1.8
1.7
—
—
—
0
0
44
116
4.02
15.13
1.9
1.4
—
—
—
0
0
138
717
2.21
13.66
2.6
2.2
11.7
13.2
umol/l
1.78
131
657
176
1018
2.05
13.11
1.9
1.6
2.3
1.1
mg/l
3.05
152
791
93
425
2.41
12.35
4.0
3.5
1.9
2.2
mmol/l
0.34
80
345
389
4634
0.51
11.97
3.7
4.2
1.4
1.3
mmol/l
1.99
345
4154
412
4807
0.51
11.49
4.7
4.8
6.1
6.0
mmol/l
0.62
371
4320
12
11
11.12
11.09
3.8
1.9
—
—
—
0
0
64
276
2.48
9.58
1.6
1.5
—
—
—
0
0
20
43
4.78
8.88
2.4
3.3
2.8
1.6
%
0.45
15
35
153
952
1.82
8.67
3.5
4.0
79.5
217.9
ng/l
1.71
120
759
393
4552
0.58
8.25
5.1
5.0
2.1
2.2
mu/l
0.27
355
4111
26
73
3.68
8.21
1.2
1.2
—
—
—
0
0
45
183
2.58
7.61
5.4
4.2
1.3
1.4
mmol/l
0.10
45
178
320
3861
0.62
7.30
4.7
4.1
14.7
14.9
pmol/l
1.23
294
3476
12
19
6.43
7.27
1.8
2.2
—
—
—
0
0
35
128
2.85
7.25
1.7
3.0
—
—
—
0
0
32
119
2.79
6.45
1.3
1.2
—
—
—
0
0
18
47
3.92
6.30
1.1
2.5
—
377.4
u/ml
—
0
5
173
1213
1.61
6.04
2.2
2.2
2.7
3.1
mg/l
1.87
147
1016
18
53
3.47
5.34
3.7
2.1
7.3
135.4
u/l
—
6
18
295
2374
1.49
5.32
9.6
5.2
0.0
0.0
estimate
0.50
49
418
104
660
1.70
5.30
15.2
26.4
1.3
1.3
inr
0.00
13
85
297
2395
1.49
5.30
7.0
3.9
0.0
0.0
estimate
0.00
49
413
20
64
3.20
5.23
1.4
1.2
—
—
—
0
0
75
439
1.81
5.05
2.1
3.1
109.0
204.0
ng/l
3.30
64
405
11
23
4.86
5.03
1.5
1.4
—
—
—
0
0
17
51
3.40
4.92
1.8
1.8
—
—
—
0
0
89
1340
0.60
4.61
1.5
1.6
1.4
1.4
mmol/l
0.44
72
1114
52
889
0.54
4.31
1.2
1.3
10.4
13.2
u/ml
0.11
16
319
12
31
3.93
4.27
1.2
1.3
0.6
0.4
nmol/l
—
5
25
76
471
1.71
4.21
4.5
2.9
—
—
—
0
0
23
92
2.56
4.09
1.4
1.4
—
—
—
0
0
34
163
2.15
4.06
4.1
2.0
853.5
312.8
ug/l
0.69
34
152
22
88
2.56
3.92
1.5
1.4
—
—
—
0
0
16
54
3.02
3.87
1.4
1.4
—
—
—
0
0
15
50
3.05
3.71
1.4
1.1
—
—
—
0
0
42
226
1.93
3.70
4.1
2.9
1.3
1.1
%
0.29
42
226
29
137
2.18
3.61
1.4
1.7
—
—
—
0
0
41
221
1.92
3.60
4.2
2.9
0.6
0.6
%
0.08
41
212
15
51
2.99
3.60
1.4
1.1
—
—
—
0
0
15
51
2.99
3.60
1.4
1.1
—
—
—
0
0
12
332
0.35
3.53
1.9
1.7
—
—
—
0
0
28
132
2.18
3.51
1.5
1.3
209.7
314.9
ug/g
1.76
20
77
21
87
2.47
3.51
1.4
1.6
—
—
—
0
0
72
463
1.63
3.48
2.7
2.5
7.9
6.2
ug/l
0.19
65
403
20
82
2.49
3.42
1.5
1.4
—
—
—
0
0
20
82
2.49
3.42
1.5
1.4
—
—
—
0
0
15
53
2.88
3.38
1.5
1.1
—
—
—
0
0
15
53
2.88
3.38
1.5
1.1
—
—
—
0
0
50
298
1.74
3.21
4.2
3.1
111.7
127.9
g/l
6.22
50
289
61
385
1.65
3.18
5.1
2.1
56.2
64.4
ml/min/173m2
1.20
26
156
20
85
2.40
3.18
4.9
3.2
60.7
58.8
%
0.29
20
85
338
2947
1.35
3.15
4.5
2.8
67.6
46.0
u/l
2.17
314
2700
19
82
2.36
2.94
4.7
2.9
4.1
4.4
e9/l
0.27
19
82
34
185
1.89
2.94
1.4
1.6
2.3
1.6
g/l
2.50
28
162
506
5302
0.65
2.94
54.2
18.7
120.5
134.2
g/l
64.62
495
5195
506
5301
0.65
2.91
53.7
18.6
4.1
4.5
e12/l
36.56
484
5114
21
96
2.23
2.86
1.4
1.2
—
—
—
0
0
14
53
2.68
2.81
1.5
1.1
—
—
—
0
0
12
42
2.90
2.76
1.6
1.5
—
—
—
0
0
13
48
2.75
2.73
1.2
1.3
—
—
—
0
0
63
914
0.65
2.66
1.2
1.3
14.9
38.5
iu/ml
2.96
11
289
7
15
4.71
2.60
1.0
1.6
98.1
87.9
%
—
7
15
16
68
2.39
2.57
1.4
1.4
—
—
—
0
0
11
39
2.86
2.48
1.9
1.8
—
—
—
0
0
14
57
2.49
2.46
1.0
1.1
—
—
—
0
0
273
2361
1.29
2.46
7.3
3.9
0.0
0.0
estimate
0.00
50
424
31
176
1.80
2.39
2.2
1.7
—
—
—
0
0
176
2099
0.77
2.23
2.5
2.3
75.0
79.1
nmol/l
1.22
162
1831
190
1584
1.30
2.22
3.0
3.0
1488.9
1337.1
ng/l
0.21
170
1329
15
68
2.24
2.12
1.5
1.3
—
—
—
0
0
11
43
2.59
2.10
1.2
1.3
—
—
—
0
0
8
25
3.23
2.10
1.7
1.1
26.5
30.9
umol/l
—
8
25
5
10
5.03
2.07
1.4
1.0
—
—
—
0
0
13
56
2.35
2.06
1.5
1.2
—
—
—
0
0
7
20
3.53
2.06
5.9
1.4
221.0
201.1
u/l
—
7
20
6
158
0.37
1.91
1.2
1.2
—
12.4
—
0
28
500
4755
1.37
1.88
32.2
12.4
42.0
22.2
mg/l
24.13
478
3663
5
12
4.19
1.82
3.6
1.3
—
—
—
0
0
140
1678
0.78
1.77
3.4
3.9
13.4
7.9
mg/mmol
0.89
85
995
6
18
3.36
1.75
2.5
2.2
5.8
13.3
nmol/l
—
6
13
8
30
2.69
1.73
1.0
1.1
—
—
—
0
0
7
163
0.42
1.69
1.1
1.2
—
21.8
—
0
7
6
19
3.18
1.66
1.3
1.1
44.2
21.3
u/l
—
6
14
8
31
2.60
1.66
1.0
1.2
—
—
—
0
0
9
187
0.47
1.64
3.3
1.9
—
—
—
0
0
27
166
1.66
1.64
2.1
1.6
—
—
—
0
0
5
131
0.38
1.64
1.0
1.2
—
—
—
0
0
6
20
3.02
1.58
1.3
1.1
91.3
80.7
u/l
—
6
15
5
125
0.39
1.51
1.0
1.2
—
10.7
—
0
9
6
21
2.88
1.51
1.3
1.6
—
—
—
0
0
25
155
1.64
1.49
1.2
1.1
—
—
—
0
0
25
155
1.64
1.49
1.2
1.1
—
—
—
0
0
9
38
2.39
1.46
1.2
1.2
—
—
—
0
0
9
38
2.39
1.46
1.2
1.2
—
—
—
0
0
9
38
2.39
1.46
1.2
1.2
—
—
—
0
0
5
16
3.14
1.44
1.2
1.0
—
—
—
0
0
5
16
3.14
1.44
1.0
1.2
—
—
—
0
0
94
756
1.29
1.42
1.3
1.4
—
—
—
0
0
7
29
2.43
1.39
1.1
1.1
—
—
—
0
0
9
41
2.21
1.37
2.4
1.6
—
—
—
0
0
141
1197
1.23
1.36
3.1
2.3
336.6
6214.5
umol/l
4.25
128
1001
50
666
0.73
1.36
4.1
5.0
31.6
33.1
%
0.37
35
415
19
114
1.69
1.29
1.5
1.3
—
—
—
0
0
85
1038
0.79
1.24
1.7
1.7
1335.4
1230.7
nmol/l
0.40
66
750
6
26
2.32
1.19
2.0
3.7
—
—
—
0
0
18
111
1.64
1.13
1.9
1.6
—
—
—
0
0
13
73
1.80
1.11
2.0
1.2
0.9
0.6
nmol/l
0.51
13
65
6
123
0.48
1.06
1.2
1.2
—
40.6
—
0
12
33
238
1.41
1.05
3.1
3.1
25.5
25.5
mmol/l
0.01
33
228
32
230
1.41
1.04
1.2
1.3
—
—
—
0
0
11
61
1.82
0.99
1.4
1.2
—
—
—
0
0
5
23
2.18
0.98
1.2
1.6
—
—
—
0
0
5
23
2.18
0.98
1.2
1.6
—
—
—
0
0
147
1303
1.17
0.90
7.8
4.1
0.0
0.0
estimate
0.50
50
411
6
29
2.08
0.89
1.5
1.3
—
—
—
0
0
7
128
0.54
0.89
1.6
1.5
—
—
—
0
0
6
31
1.95
0.84
1.8
1.4
—
—
—
0
0
500
5125
0.83
0.84
24.7
9.0
25.0
24.2
u/l
0.58
486
4891
15
97
1.56
0.82
1.3
1.2
—
—
—
0
0
25
182
1.39
0.79
3.8
6.2
24.9
24.8
mmol/l
0.03
25
172
0
26
0.00
0.78
0.0
1.4
—
—
—
0
0
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
9
55
1.65
0.73
1.4
1.2
—
—
—
0
0
149
1646
0.87
0.73
2.6
3.1
6.3
6.8
mmol/l
0.78
117
1362
34
428
0.78
0.68
1.4
1.6
1.6
1.5
%
0.26
28
370
7
44
1.60
0.65
1.3
1.0
—
—
—
0
0
19
257
0.73
0.64
1.5
1.6
—
—
—
0
0
22
289
0.75
0.61
1.6
1.8
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
5
87
0.57
0.56
1.0
1.5
—
—
—
0
0
9
60
1.51
0.54
1.1
1.1
—
—
—
0
0
438
4498
0.89
0.54
35.6
11.3
78.1
76.8
ml/min/173m2
0.65
405
3595
215
2017
1.10
0.54
2.8
2.6
219.6
109.0
ug/l
5.70
199
1825
33
268
1.25
0.54
3.6
5.2
1.5
1.8
mmol/l
0.18
28
208
136
1245
1.12
0.53
1.6
1.5
20.3
21.7
nmol/l
0.51
123
1044
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
119
1088
1.12
0.48
6.6
4.3
1.0
1.0
kg/l
0.37
17
159
203
2153
0.91
0.47
2.0
2.0
87.4
96.7
pmol/l
2.16
120
1037
250
2623
0.92
0.46
2.8
2.6
—
—
—
0
0
7
50
1.40
0.45
1.1
1.0
—
2.3
—
0
22
70
783
0.88
0.43
3.4
3.6
25.0
24.4
%
0.05
30
363
11
151
0.72
0.43
1.6
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
91
995
0.90
0.40
4.0
3.8
2.2
2.1
ug/l
0.14
78
872
8
61
1.32
0.39
1.0
1.3
—
—
—
0
0
205
1947
1.08
0.38
4.0
3.7
26.3
52.0
ng/l
0.81
161
1391
9
68
1.33
0.37
1.2
1.4
—
—
—
0
0
12
158
0.75
0.37
1.0
1.4
—
—
—
0
0
22
180
1.23
0.36
1.4
1.6
—
107.5
—
0
8
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
28
236
1.20
0.35
1.0
1.0
—
—
—
0
0
23
191
1.21
0.34
2.5
1.3
3.8
3.8
g/l
0.03
18
133
23
191
1.21
0.34
2.5
1.3
—
—
—
0
0
23
191
1.21
0.34
2.5
1.3
8.4
7.6
g/l
0.63
18
137
12
155
0.77
0.33
1.9
1.7
0.2
0.2
g/l
0.01
12
149
6
47
1.28
0.32
1.3
1.6
—
—
—
0
0
193
1841
1.07
0.32
6.6
4.0
—
—
—
0
0
15
119
1.27
0.32
1.2
1.1
—
—
—
0
0
7
54
1.30
0.30
1.1
1.3
—
120.1
—
0
8
13
161
0.80
0.27
1.8
1.7
1.2
1.2
g/l
0.38
13
152
5
73
0.68
0.26
6.0
4.3
385.6
365.1
umol/l
—
5
62
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
50
541
0.92
0.20
2.5
2.6
0.6
0.8
ug/l
1.57
34
358
15
127
1.19
0.19
1.7
1.2
0.0
0.0
g/l
0.00
15
116
374
3678
1.05
0.19
3.6
4.3
22.1
12.6
mm/h
9.68
337
3372
29
320
0.90
0.17
1.1
1.2
35.2
127.1
iu/ml
—
7
133
101
1057
0.95
0.17
1.2
1.2
0.7
2.1
u/ml
1.86
21
288
16
138
1.16
0.17
2.1
1.3
1.2
0.0
g/l
0.57
16
124
12
101
1.19
0.16
1.7
1.8
121.7
130.8
g/l
—
7
73
15
130
1.16
0.15
1.7
1.2
0.2
0.0
g/l
0.74
15
117
12
139
0.86
0.14
2.3
1.3
37.5
40.9
mg/l
0.14
12
115
12
139
0.86
0.14
2.3
1.3
31.0
30.4
mg/l
0.03
12
115
12
105
1.15
0.11
4.3
7.0
8.3
8.1
kpa
0.13
12
98
14
125
1.12
0.10
1.6
1.7
—
—
—
0
0
10
87
1.15
0.09
1.9
1.4
306.4
315.4
mu/l
—
10
78
70
675
1.04
0.09
1.4
1.4
—
—
—
0
0
7
67
1.05
0.08
1.0
1.4
—
—
—
0
0
6
71
0.84
0.07
2.2
1.3
—
—
—
0
0
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
157
1595
0.98
0.06
2.6
2.1
122.5
197.8
u/l
2.48
151
1496
9
104
0.86
0.06
1.3
1.6
—
—
—
0
0
14
129
1.09
0.05
2.4
2.3
11.2
12.9
mg/l
0.36
14
117
14
151
0.93
0.05
1.2
1.4
—
—
—
0
0
112
1139
0.98
0.05
1.8
1.7
126087421.6
6572189.4
pmol/l
0.46
92
913
503
5044
0.98
0.04
40.0
15.2
4.0
4.0
mmol/l
0.20
492
4883
12
123
0.98
0.00
1.7
1.7
3.5
5.8
iu/l
—
5
44
424
4243
1.00
0.00
40.2
14.0
35.9
39.4
%
13.06
303
2801
70
698
1.00
0.00
16.0
6.9
—
—
—
0
0
503
5032
1.00
0.00
40.0
15.1
138.6
139.7
mmol/l
15.26
492
4883
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
0.00
2.6
3.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
88.0
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RETROPERITONEUM_PERITONEUM_EXALLC – Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).